The Biolocity Oversight Committee serves as both an advisory council and a decision-making board to select funded projects. The committee comprises clinical, industry, regulatory, investment, and entrepreneurial veterans with relevant technology and medical expertise and partner university technology transfer advisers.

Mary Albertson, CLP, RTTP
Director of Technology Licensing at Georgia Tech Research Corporation

Kirk Barnes, BA
Co-founder and President of Start-Up Commercialization and Sales Training of TransPharMed

Ibraheem Badejo, Ph.D.
Senior R&D Director, Ethicon External Front End Innovation at Johnson & Johnson

Mark Boden, Ph.D.
Senior Fellow/Technology Scout, Boston Scientific Corporation

Justin Burns, Ph.D.
Vice President, Innovation & Entrepreneurship, GRA

Monte Eaves, MD
Director, American Board of Plastic Surgery and Founder & CEO, Brijjit Co, LLC

Andrés J. García, Ph.D.
Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience

Michelle Ho, Ph.D.
Senior Associate, 5AM Ventures

Derek Mazur, MSc
Private Company Investor, Cedar Pine

Rifat Pamukcu, MD
President & CEO, Midway Pharmaceuticals Inc.

Alyssa Panitch, Ph.D.
Professor and Chair of the Wallace H. Coulter Department of Biomedical Engineering

Shyam Parekh, Ph.D., MBA
Parekh Advisory Services

Jay Parrish, Ph.D.
Venture Partner, Arch Ventures

Preetha Ram, Ph.D.
Sr. Managing Partner, Pier 70

Todd Sherer, Ph.D.
Associate VP for Research Administration & Executive Director, Office of Technology Transfer, Emory University

Robert Taylor, MD
Professor of Medicine, Director, Division of Cardiology, Emory University School of Medicine

Robert Towarnicki, MS
Managing Partner, New Hope BioConsulting LLC and CEO, SIRPant Immunotherapeutics

David Wright, MD
Associate Professor and Director, Emergency Neurosciences at Emory University School of Medicine

Bob Yoder, MBA
Senior Vice President and Chief Business Officer, Trevena, Inc.